Graf Akcie EXEL (Exelixis Inc). Diskuze k akciím EXEL. Aktuální informace EXEL.

Základní informace o společnosti Exelixis Inc (Akcie EXEL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 6.84B
Hodnota podniku (EV) 5.06B
Tržby 1.157B
EBITDA 111.778M
Zisk 94.041M
Růst v tržbách Q/Q 48.44 %
Růst v tržbách Y/Y 15.84 %
P/E (Cena vůči ziskům) 70.39
Forward P/E 0.29
EV/Sales 4.37
EV/EBITDA 45.25
EV/EBIT 44.77
PEG 0.40
Price/Sales 5.92
P/FCF 31.38
Price/Book 3.64
Účetní hodnota na akcii 5.99
Hotovost na akcii 3.85
FCF vůči ceně 3.19 %
Počet zaměstnanců 773
Tržba na zaměstnance 1496000
Profit margin 11.32 %
Operating margin 8.66 %
Gross margin 96.33 %
EBIT margin 9.77 %
EBITDA margin 9.66 %
EPS - Zisk na akcii 0.31
EPS - Kvartální růst 42.86 %
EPS - Očekávaný růst příští rok -240.00 %
Return on assets 4.27 %
Return on equity 4.89 %
ROIC 6.50 %
ROCE 5.35 %
Dluhy/Equity 0.14
Čistý dluh/EBITDA -42.26
Current ratio 6.24
Quick Ratio 6.14
Volatilita 2.54
Beta 0.78
RSI 65.31
Cílová cena analytiků 31
Známka akcie (dle analytiků) 1.57
Insider ownership 2.17 %
Institutional ownership 85.05 %
Počet akcií 315.049M
Procento shortovaných akcií 3.59 %
Short ratio 5.26 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie EXEL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$987.538$967.775$853.826$452.477$191.454$37.172
Cost Of Goods Sold$36.272$33.097$26.348$15.066$6.552$3.895
Gross Profit$951.266$934.678$827.478$437.411$184.902$33.277
Research And Development Expenses$547.851$336.964$182.257$112.171$95.967$96.351
SG&A Expenses$293.355$228.244$206.366$159.33$116.145$57.305
Other Operating Income Or Expenses------
Operating Expenses$877.478$598.305$414.971$286.567$219.578$158.593
Operating Income$110.06$369.47$438.855$165.91$-28.124$-121.421
Total Non-Operating Income/Expense$20.777$28.639$13.237$-7.333$-42.098$-40.268
Pre-Tax Income$130.837$398.109$452.092$158.577$-70.222$-161.689
Income Taxes$19.056$77.097$-237.978$4.35-$0.055
Income After Taxes$111.781$321.012$690.07$154.227$-70.222$-161.744
Other Income------
Income From Continuous Operations$111.781$321.012$690.07$154.227$-70.222$-161.744
Income From Discontinued Operations------
Net Income$111.781$321.012$690.07$154.227$-70.222$-161.744
EBITDA$119.201$377.818$443.77$167.097$-18.69$-102.974
EBIT$110.06$369.47$438.855$165.91$-28.124$-121.421
Basic Shares Outstanding308303298294251209
Shares Outstanding318315313312251209
Basic EPS$0.36$1.06$2.32$0.52$-0.28$-0.77
EPS - Earnings Per Share$0.35$1.02$2.21$0.49$-0.28$-0.77
# 2020 2019 2018 2017 2016 2015
Current Ratio7.06257.08388.50484.21011.74493.4194
Long-term Debt / Capital---0.0498-1.5081
Debt/Equity Ratio---0.05241.2217-2.9682
Gross Margin96.32796.580196.914196.670396.577889.5217
Operating Margin11.144938.177351.398736.6671-14.6897-326.6464
EBIT Margin11.144938.177351.398736.6671-14.6897-326.6464
EBITDA Margin12.070539.039951.974336.9294-9.7621-277.0204
Pre-Tax Profit Margin13.248841.136552.94935.0464-36.6783-434.9753
Net Profit Margin11.319233.170180.820934.0851-36.6783-435.1232
Asset Turnover0.4620.51320.60030.69050.32140.1118
Inventory Turnover Ratio1.72952.56842.67822.26321.96291.4889
Receiveable Turnover6.13858.12765.24565.57294.73387.1719
Days Sales In Receivables59.460444.908869.582665.495277.10550.893
ROE - Return On Equity5.948619.040253.599654.1221-78.6201114.8701
Return On Tangible Equity6.157319.787656.388969.6986-273.940679.0963
ROA - Return On Assets5.229917.023848.518423.5355-11.7874-48.6679
ROI - Return On Investment5.948619.040253.599651.4263-78.6202-58.3637
Book Value Per Share6.035.53084.29330.9620.3081-0.6177
Operating Cash Flow Per Share-1.01560.34380.7982-0.3091.5140.5374
Free Cash Flow Per Share-1.07040.40850.76-0.36981.50330.5421

Porovnání s konkurencí: Akcie EXEL

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
EXEL 70.39 0.40 15.84 % -240.00 % 4.89 % 3.64 11.32 %
Akcie AMGN 20.99 1.66 4.87 % -2.29 % 60.57 % 12.44 28.57 %
Akcie BMY N/A 14.08 27.31 % 19.02 % -12.51 % 3.43 -21.20 %
Akcie AVEO N/A N/A -50.16 % 9.09 % -106.87 % 6.22 -591.19 %
Akcie CRIS N/A N/A -8.66 % 18.18 % -40.73 % 5.15 -276.03 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %
Akcie JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %

Nedávné obchody insiderů: Akcie EXEL

Jméno Obchod Cena Objem
Jeffrey Hessekiel
EVP and General Counsel
Option
15 Nov 2020
$7.27 $218,100
Vincent T Marchesi
Director
Option
24 Nov 2020
$5.82 $232,823
Lance Willsey
Director
Option
4 Dec 2020
$5.82 $617,746
Peter Lamb
EVP, Scientific Strategy, and CSO
Option
18 Dec 2020
$1.70 $110,500
Jeffrey Hessekiel
EVP and General Counsel
Option
4 Jan 2021
$5.12 $256,000
Peter Lamb
EVP, Scientific Strategy, and CSO
Option
4 Jan 2021
$1.70 $110,500
Christopher J. Senner
EVP and CFO
Option
12 Jan 2021
$3.66 $109,800
Peter Lamb
EVP, Scientific Strategy, and CSO
Option
1 Feb 2021
$1.70 $110,500
Patrick J. Haley
EVP and Commercial
Prodej
12 Feb 2021
$21.57 $970,650
Carl B Feldbaum
Director
Option
16 Feb 2021
$3.38 $67,600
Gisela Schwab
Pres, Prod Dev, Med Aff, and CMO
Option
17 Feb 2021
$1.70 $170,000

Diskuze k akciím EXEL